©2010 Baishideng.
World J Gastroenterol. Feb 28, 2010; 16(8): 934-947
Published online Feb 28, 2010. doi: 10.3748/wjg.v16.i8.934
Published online Feb 28, 2010. doi: 10.3748/wjg.v16.i8.934
| Schedule | Monotherapy | Combination therapy | |
| Prednisone only1 (mg/d) | Prednisone1 (mg/d) | Azathioprine (mg/d) | |
| Induction period | |||
| Week 1 | 60 | 30 | 50 |
| Week 2 | 40 | 20 | 50 |
| Week 3 | 30 | 15 | 50 |
| Week 4 | 30 | 15 | 50 |
| Maintenance period | |||
| Fixed doses until end point | 20 | 10 | 50 |
| Conditions that favor each regimen | Cytopenia (severe) Absent thiopurine methyltransferase activity Pregnancy Malignancy (active) Short trial ( ≤ 6 mo) Acute severe onset | Elderly/postmenopausal state Osteoporosis Brittle diabetes Obesity Acne Emotional instability/psychosis Hypertension Prolonged therapy (≥ 6 mo) | |
- Citation: Czaja AJ. Difficult treatment decisions in autoimmune hepatitis. World J Gastroenterol 2010; 16(8): 934-947
- URL: https://www.wjgnet.com/1007-9327/full/v16/i8/934.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i8.934